Association of Mitochondrial Genetic Variation with Carotid Atherosclerosis

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Sobenin, Igor A ^a,b   Sazonova, Margarita A ^b   Postnov, Anton Y ^a   Salonen, Jukka T ^c,d   Bobryshev, Yuri V ^e,f   Orekhov, Alexander N ^b,e  

^a INSTITUTE OF EXPERIMENTAL CARDIOLOGY   (Russian Federation)

^b INSTITUTE OF GENERAL PATHOLOGY AND PATHOPHYSIOLOGY   (Russian Federation)

^c MAS Metabolic Analytical Services Oy   (Finland)

^d UNIVERSITY OF HELSINKI   (Finland)

^e Skolkovo Innovative Center   (Russian Federation)

^f UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

MITOCHONDRIAL DNA;

ADULT; AGED; ARTERIAL WALL THICKNESS; ARTICLE; B SCAN; CAROTID ATHEROSCLEROSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; HETEROPLASMY; HUMAN; HUMAN CELL; ISCHEMIC HEART DISEASE; LEUKOCYTE; MALE; MITOCHONDRIAL GENOME; PYROSEQUENCING; RUSSIAN FEDERATION; SOMATIC MUTATION;

AGED; ATHEROSCLEROSIS; CAROTID ARTERY DISEASES; CAROTID INTIMA-MEDIA THICKNESS; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC VARIATION; GENOME, MITOCHONDRIAL; HUMANS; LEUKOCYTES; MALE; MIDDLE AGED; MITOCHONDRIA; MUTATION; RISK FACTORS; ROC CURVE;

EID: 84879936980     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0068070     Document Type: Article

References (43)

1. Andreu AL, Hanna MG, Reichmann H, Bruno C, Penn AS, et al. (1999) Exercise intolerance due to mutations in the cytochrome b gene of mitochondrial DNA. N Engl J Med 341: 1037-1044.
2. Chol M, Lebon S, Bénit P, Chretien D, de Lonlay P, et al. (2003) The mitochondrial DNA G13513A MELAS mutation in the NADH dehydrogenase 5 gene is a frequent cause of Leigh-like syndrome with isolated complex I deficiency. J Med Genet 40: 188-191.
3. Han CB, Ma JM, Xin Y, Mao XY, Zhao YJ, et al. (2005) Mutations of mitochondrial 12S rRNA in gastric carcinoma and their significance. World J Gastroenterol 11: 31-35.
4. Tanimoto H, Nishio H, Matsuo M, Nibu K, (2004) A novel mitochondrial mutation, 1556CT, in a Japanese patient with streptomycin-induced tinnitus. Acta Otolaryngol 124: 258-261.
5. Yamagata K, Muro K, Usui J, Hagiwara M, Kai H, et al. (2002) Mitochondrial DNA mutations in focal segmental glomerulosclerosis lesions. J Am Soc Nephrol 13: 1816-1823.
6. Matsunaga H, Tanaka Y, Tanaka M, Gong JS, Zhang J, et al. (2001) Antiatherogenic mitochondrial genotype in patients with type 2 diabetes. Diabetes Care 24: 500-503.
7. Wong LJ, Chen TJ, Tan DJ, (2004) Detection of Mitochondrial DNA Mutations by Temporal Temperature Gradient Gel Electrophoresis. Electrophoresis 25: 2602-2610.
8. Fu K, Hartlen R, Johns T, Genge A, Karpati G, et al. (1996) A novel heteroplasmic tRNAleu(CUN) mtDNA point mutation in a sporadic patient with mitochondrial encephalomyopathy segregates rapidly in skeletal muscle and suggests an approach to therapy. Hum Mol Genet 5: 1835-1840.
9. Solano A, Roig M, Vives-Bauza C, Hernandez-Peña J, Garcia-Arumi E, et al. (2003) Bilateral striatal necrosis associated with a novel mutation in the mitochondrial ND6 gene. Ann Neurol 54: 527-530.
10. Horváth R, Scharfe C, Hoeltzenbein M, Do BH, Schröder C, et al. (2002) Childhood onset mitochondrial myopathy and lactic acidosis caused by a stop mutation in the mitochondrial cytochrome C oxidase III gene. J Med Genet 39: 812-816.
11. Kim DS, Jung DS, Park KH, Kim IJ, Kim CM, et al. (2002) Histochemical and molecular genetic study of MELAS and MERF in Korean patients. J Korean Med Sci 17: 103-112.
12. Varlamov DA, Kudin AP, Vielhaber S, Schröder R, Sassen R, et al. (2002) Metabolic consequences of a novel missense mutation of the mtDNA CO I gene. Hum Mol Genet 11: 1797-1805.
13. Gropman A, Chen TJ, Perng CL, Krasnewich D, Chernoff E, et al. (2004) Variable clinical manifestation of homoplasmic G14459A mitochondrial DNA mutation. Am J Med Genet A 124: 377-382.
14. Man PY, Griffiths PG, Brown DT, Howell N, Turnbull DM, et al. (2003) The epidemiology of Leber hereditary optic neuropathy in the North East of England. Am J Hum Genet 72: 333-339.
15. Nishigaki Y, Martí R, Copeland WC, Hirano M, (2003) Site-specific somatic mitochondrial DNA point mutations in patients with thymidine phosphorylase deficiency. J Clin Invest 111: 1913-1921.
16. Baracca A, Barogi S, Carelli V, Lenaz G, Solaini G, (2000) Catalytic activities of mitochondrial ATP synthase in patients with mitochondrial DNA T8993G mutation in the ATPase 6 gene encoding subunit a. J Biol Chem 275: 4177-4182.
17. Jeppesen TD, Schwartz M, Hansen K, Danielsen ER, Wibrand F, et al. (2003) Late onset of stroke-like episode associated with a 3256CT point mutation of mitochondrial DNA. J Neurol Sci 214: 17-20.
18. Sazonova MA, Budnikov EY, Khasanova ZB, Sobenin IA, Postnov AY, et al. (2009) Studies of the human aortic intima by a direct quantitative assay of mutant alleles in the mitochondrial genome. Atherosclerosis 204: 184-190.
19. Sobenin IA, Sazonova MA, Postnov AY, Bobryshev YV, Orekhov AN, (2012) Mitochondrial Mutations are Associated with Atherosclerotic Lesions in the Human Aorta. Clin Dev Immunol 2012: 832464.
20. Sobenin IA, Sazonova MA, Ivanova MM, Zhelankin AV, Myasoedova VA, et al. (2012) Mutation C3256T of Mitochondrial Genome in White Blood Cells: Novel Genetic Marker of Atherosclerosis and Coronary Heart Disease. PLoS ONE 7: e46573.
21. Moraes CT, Ciacci F, Bonilla E, Jansen C, Hirano M, et al. (1993) Two novel pathogenic mitochondrial DNA mutations affecting organelle number and protein synthesis. Is the tRNALeu(UUR) gene an etiologic hot spot? J Clin Invest 92: 2906-2915.
22. Rossmanith W, Karwan RM, (1998) Impairment of tRNA processing by point mutations in mitochondrial tRNA(Leu) (UUR) associated with mitochondrial diseases. FEBS Letters 433: 269-274.
23. Levinger L, Morl M, Florentz C, (2004) Mitochondrial tRNA 3′ end metabolism and human disease. Nucl Acids Res 32: 5430-5441.
24. Karadimas CL, Salviati L, Sacconi S, Chronopoulou P, Shanske S, et al. (2002) Mitochondrial myopathy and ophthalmoplegia in a sporadic patient with the G12315A mutation in mitochondrial DNA. Neuromuscul Disord 12: 865-868.
25. Valente L, Piga D, Lamantea E, Carrara F, Uziel G, et al. (2009) Identification of novel mutations in five patients with mitochondrial encephalomyopathy. Biochim Biophys Acta 1787: 491-501.
26. Sudo A, Honzawa S, Nonaka I, Goto Y, (2004) Leigh syndrome caused by mitochondrial DNA G13513A mutation: frequency and clinical features in Japan. J Hum Genet 49: 92-96.
27. Shanske S, Coku J, Lu J, Ganesh J, Krishna S, et al. (2008) The G13513A mutation in the ND5 gene of mitochondrial DNA as a common cause of MELAS or Leigh syndrome: evidence from 12 cases. Arch Neurol 65: 368-372.
28. Lim BC, Park JD, Hwang H, Kim KJ, Hwang YS, et al. (2009) Mutations in ND subunits of complex I are an important genetic cause of childhood mitochondrial encephalopathies. J Child Neurol 24: 828-832.
29. Funalot B, Reynier P, Vighetto A, Ranoux D, Bonnefont JP, et al. (2002) Leigh-like encephalopathy complicating Leber's hereditary optic neuropathy. Annals Neurol 52: 374-377.
30. Kirby DM, Boneh A, Chow CW, Ohtake A, Ryan MT, et al. (2003) Low mutant load of mitochondrial DNA G13513A mutation can cause Leigh's disease. Annals Neurol 54: 473-478.
31. Tarnopolsky MA, Baker SK, Myint T, Maxner CE, Robitaille J, et al. (2004) Clinical variability in maternally inherited Leber Hereditary Optic Neuropathy with the G14459A mutation. Am J Med Genet 124A: 372-376.
32. Andreu AL, Bruno C, Dunne TC, Tanji K, Shanske S, et al. (1999) A nonsense mutation (G15059A) in the cytochrome b gene in a patient with exercise intolerance and myoglobinuria. Annals Neurol 45: 127-130.
33. Filosto M, Mancuso M, Vives-Bauza C, Vila MR, Shanske S, et al. (2003) Lack of paternal inheritance of muscle mitochondrial DNA in sporadic mitochondrial myopathies. Annals Neurol 54: 524-526.
34. Elliott HR, Samuels DC, Eden JA, Relton CL, Chinnery PF, (2008) Pathogenic mitochondrial DNA mutations are common in the general population. Am J Hum Genet 83: 254-260.
35. Koopman WJH, Willems PHGM, Smeitink JAM, (2012) Monogenic mitochondrial disorders. N Engl J Med 366: 1132-1141.
36. Meierhofer D, Mayr JA, Ebner S, Sperl W, Kofler B, (2005) Rapid screening of the entire mitochondrial DNA for low-level heteroplasmic mutations. Mitochondrion 5: 282-296.
37. Galkina E, Ley K, (2007) Leukocyte influx in atherosclerosis. Curr Drug Targets 8: 1239-1248.
38. Galkina E, Ley K, (2009) Immune and inflammatory mechanisms of atherosclerosis. Annu Rev Immunol 27: 165-197.
39. Salonen R, Nyyssönen K, Porkkala E, Rummukainen J, Belder R, et al. (1995) Atherosclerosis Prevention Study (KAPS). A population-based primary preventive trial of the effect of LDL lowering on atherosclerotic progression in carotid and femoral arteries. Circulation 92: 1758-1764.
40. Baldassarre D, Nyyssönen K, Rauramaa R, de Faire U, Hamsten A, et al. (2010) Cross-sectional analysis of baseline data to identify the major determinants of carotid intima-media thickness in a European population: the IMPROVE study. Eur Heart J 31: 614-622.
41. Alderborn A, Kristofferson A, Hammerling U, (2000) Determination of single-nucleotide polymorphisms by real-time pyrophosphate DNA sequencing. Genome Res 10: 1249-1258.
42. Chen DC, Saarela J, Nuotio I, Jokiaho A, Peltonen L, et al. (2003) Comparison of GenFlex Tag array and pyrosequencing in SNP genotyping. J Mol Diagn 5: 243-249.
43. Sinclair A, Arnold C, Woodford N, (2003) Rapid detection and estimation by pyrosequencing of 23S rRNA genes with a single nucleotide polymorphism conferring linezolid resistance in Enterococci. Antimicrob Agents Chemother 47: 3620-3622.